Zydus Lifesciences receives USFDA warning letter for Baddi facility
Zydus Lifesciences Ltd. received a warning letter from the US Food and Drug Administration (USFDA) on Wednesday, June 3, for its formulation manufacturing facility in Baddi, Himachal Pradesh. In an exchange filing, the drugmaker said the warning letter relates to a request for records under Section 704(a)(4) of the US Federal Food, Drug and Cosmetic…
